# Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach

> **NCT03540654** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 355 (actual)

## Conditions studied

- Hematologic Diseases
- Chronic Myeloid Leukemia

## Interventions

- **OTHER:** Budget impact

## Key facts

- **NCT ID:** NCT03540654
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-07
- **Primary completion:** 2018-10
- **Final completion:** 2019-04
- **Target enrollment:** 355 (ACTUAL)
- **Last updated:** 2020-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03540654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03540654, "Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03540654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*